NEWSお知らせ

2025年3月に公開された以下の論文をArticleに追加しました。

https://www.hc-c.co.jp/cost-effectiveness-analysis-of-bispecific-antibody-faricimab-for-treatment-of-neovascular-age-related-macular-degeneration-and-diabetic-macular-edema-in-japan/

Yanagi Y, Tsujimura J, Ohno S, Higashi K, Sakashita N, Shoji A, Igarashi A. Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan. J Med Econ. 2025 Mar 13:1-19. doi: 10.1080/13696998.2025.2478755. Epub ahead of print. PMID: 40078048.

論文の詳細は以下のURLからもご覧いただけます。
PubMed

https://pubmed.ncbi.nlm.nih.gov/40078048

Full text link

https://www.tandfonline.com/doi/10.1080/13696998.2025.2478755?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed#abstract